THE DEAL, AT A GLANCE
2/4 explanations supportedCalocurb
Calocurb
Calocurb sells prescription-free appetite-suppressing capsules that help manage hunger, cravings, snacking and overeating.
01What it doesCalocurb sells prescription-free appetite-suppressing capsules that help manage hunger, cravings, snacking and overeating.Source-grounded · automated review · Explore ↗
02Who is involvedEvidence still neededOpen review status ↗
The draft does not name investors and correctly states that the supplied document does not identify Series A investors or distinguish investor, arranger, or lender roles for the target financing event.
03What happenedEvidence still neededOpen review status ↗
The draft correctly states that the supplied document does not establish a Series A financing amount, currency, announcement, or date. No valuation or completed financing event is supported by document 0.
04Why it mattersThe product positions itself as a non-prescription weight-management option backed by human clinical studies.Source-grounded · automated review · Explore ↗
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
Calocurb · Financing Record
Explore source-linked visual explanations for Calocurb. Unsupported claims are withheld while source review continues.
Record 11903 · Recorded date: 2026-09-08
Explore company records →